Spanish Breast Cancer Research Group   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Madrid Spain (1995)

Organization Overview

First Clinical Trial
1999
NCT00121992
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Spanish Breast Cancer Research Group | Spanish Breast Cancer Research Group (GEICAM) | Spanish Breast Cancer Research Group (SOLTI) | Spanish Breast Cancer Reserach Group